32
Participants
Start Date
September 4, 2023
Primary Completion Date
December 24, 2023
Study Completion Date
February 5, 2024
Daridorexant
"25 mg group: Daridorexant group: strength 25 mg, administered at a dose of 25 mg; administered orally under fasting conditions, single dosing on Day1, and daily dosing on Day 4-8.~Placebo control group: administered in the same manner as the test drug.~50 mg group: Daridorexant group: strength 50 mg, administered at a dose of 50 mg; administered orally under fasting conditions, single dosing on Day 1, and daily dosing on Day 4-8.~Placebo control group: administered in the same manner as the test drug.~Drug is to be administered at the same time every day, and the dosing window is recommended to be at 08:00 AM (±1 h) on the dosing day. Drinking water and other liquids should be avoided for 1 hour before and after dosing on the day of blood collection (except the water used to swallow the tablets.)."
Nanjing Drum Tower hospital, Nanjing
Lead Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
INDUSTRY